// App-Quantinova.ai

e15124 : Correlation of circulating tumor cells (CTCs) and clinical biomarker endpoints in metastatic prostate cancer patients.

Researchers

Presenter

  • Robert J. Amato

Principal Investigators

  • Vladislava O. Melnikova

  • Yujian Zhang

  • Wen Liu

  • Yuan Wang

  • Parth K. Shah

  • Brett T Jensen

  • Karen E. Torres

  • Darren W. Davis

Medical Centers

  • The University of Texas Health Science Center at Houston, Houston, TX

  • ApoCell, Inc., Houston, TX

  • University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX.

  • University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • Circulating tumor cells

  • Prostate specific antigen

Drug/Treatment

  • Androgen Tear

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved